Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function

Cancer

Volumn 110, Issue 10, 2007, Pages 2222-2229

  Oktem, Ozgur ^a   Oktay, Kutluk ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Alkylating agents; Chemotherapy; Gonadotoxicity; Histologic assessment; Ovary; Primordial follicle; Stromal function

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ESTRADIOL; ESTROGEN; ETOPOSIDE; GEMTUZUMAB OZOGAMICIN; GONADORELIN AGONIST; IDARUBICIN; IFOSFAMIDE; LEUPRORELIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; RECOMBINANT FOLLITROPIN; VINBLASTINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; CRYOPRESERVATION; ESTRADIOL BLOOD LEVEL; ESTROGEN SYNTHESIS; FEMALE; FEMALE FERTILITY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTOLOGY; HODGKIN DISEASE; HUMAN; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; OVARY FOLLICLE; OVARY FUNCTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID TUMOR; SYNOVIAL SARCOMA; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; OVARIAN FOLLICLE;

EID: 36049006773     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23071     Document Type: Article

References (23)

1. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10:251-266.
2. Lutchman Singh K, Davies M, Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update. 2005;11:69-89.
3. Morita Y, Perez GI, Paris F et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med. 2000;10:1109-1114.
4. Plowchalk DR, Mattison DR. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide. Toxicol Appl Pharmacol. 1991;107:472-481.
5. Oktay K. Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there a germline stem cell connection? Hum Reprod. 2006;21: 1345-1348.
6. Faddy MJ, Gosden RG. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod. 1996;11:1484-1486.
7. Oktay K, Oktem O, Reh A, et al. Measuring the impact of chemotherapy on fertility in women with breast cancer. J Clin Oncol. 2006;24:4044-4046.
8. Scheffer GJ, Broekmans FJ, Looman CW, et al. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum. Reprod. 2003;18:700-706.
9. Johnson J, Bagley J, Skaznik-Wikiel M, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell. 2005;122:303-315.
10. Johnson J, Canning J, Kaneko T, et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428:145-150.
11. Oktay K, Karlikaya G, Akman O, et al. Interaction of extracellular matrix and activin-A in the initiation of follicle growth in the mouse ovary. Biol Reprod. 2000;63:457-461.
12. Oktay K, Oktem O. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Feral Steril. 2006;86(suppl 1):S95-S96.
13. Meirow D, Lewis H, Nugent D, et al. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod. 1999;14:1903-1907.
14. Cobleigh MA, Bines J, Harris D, et al. Amenorrhea following adjuvant chemotherapy for breast cancer. Proc Am Soc Clin Oncol. 1995;14:A158.
15. Reh AE, Oktem O, Lostritto K, et al. Impact of breast cancer chemotherapy on ovarian reserve: a prospective analysis by menstrual history and ovarian reserve markers. Fertil Steril. 2006;86(suppl 1):S97-S98.
16. Bonadonna G, Santoro A, Viviani S, et al. Gonadal damage in Hodgkin's disease from cancer chemotherapy regimens. Arch Toxicol. 1984;7:140-145.
17. Santoro A, Bonnadonna G, Valagussa P, et al. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol. 1987;5:27-37.
18. Lemez P, Urbanek V. Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients. Neoplasma. 2005;52:398-401.
19. Oktay K, Newton H, Mullan J, et al. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. Hum Reprod. 1998;13:1133-1138.
20. Oktay K, Briggs D, Gosden RG. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab. 1997;82:3748-3751.
21. Ryu BY, Orwig KE, Oatley JM, et al. Effects of aging and niche microenvironment on spermatogonial stem cell self-renewal. Stem Cells. 2006;24:1505-1511.
22. Lee HJ, Selesniemi K, Niikura T, et al. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J Clin Oncol. 2007;25:3198-3204.
23. Schwartz GN, Warren MK, Rothwell SW, et al. Post-chemotherapy and cytokine pretreated marrow stromal cell layers suppress hematopoiesis from normal donor CD34+ cells. Bone Marrow Transplant. 1998;22:457-468.